This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...

Acute limb ischemia occurs due to a sudden decrease in the blood flow to a limb, resulting in a potential threat to the viability of the extremity. Unfortunately, the threat is not only to the limb, ...

Acute limb ischemia means a sudden lack of blood flow to a limb because of a blood clot thrombosis or embolism and this health condition is commonly seen in people belonging to all age groups. This ...

June 20, 2012 (Dallas, Texas) — New data from the peripheral arterial disease (PAD) subgroup of the TRA 2°P TIMI 50 trial have suggested that the protease-activated receptor 1 (PAR-1) antagonist ...

SAN DIEGO — New analyses of the TRA 2P-TIMI 50 trial showed that vorapaxar use was associated with reductions in acute limb ischemia, peripheral revascularization and recurrent major CV events in ...

In a real-world setting, the downstream demands on healthcare resources entailed by first-line use of catheter-directed thrombolysis in nonembolic acute limb ischemia (ALI) make it a less ...

Patients with peripheral artery disease who have undergone lower-extremity revascularization are at high risk for major adverse limb and cardiovascular events. The efficacy and safety of rivaroxaban ...

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that early ...

Patients undergoing surgical revascularization for critical limb ischemia do not benefit from a ‘controlled reperfusion’ strategy aimed at minimizing reperfusion injury, according to data from a ...

Ischemia requiring hospital admission is associated with an elevated risk of limb amputation, cardiovascular events and death. Around 20% of patients will require amputation.1 The incidence of acute ...